May
Medicinal Chemistry
Strategy Meeting West Coast USA 2024
Reinvigorating Productivity in Pharma & Biotech R&D Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms
What makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at Medicinal Chemistry Strategy Meeting.
Andrea Small-Howard
President GB SciencesArun Thottumkara
Director of Chemistry, Enabling Science Odyssey TherapeuticsBrock Shireman
Vice President, Head of Chemistry Rapport TherapeuticsBryce Allen
Co-founder & CEO Differentiated TherapeuticsChris Stumpf
Senior Principal Product Marketing Manager for Drug Discovery Informatics Solutions Revvity SignalsDustin Cefalo, Ph.D
Vice President of Chemistry FRONTIERFrederick Chang
CEO KekulaiLalit K Sharma
Co-founder and CSO NoraChemPrasun Mishra
CEO, Founder / CEO, Founding President r, Agility Pharmaceuticals / American Association for Precision Medicine (AAPM)Thomas Brady
Senior Principal Scientist Cidara TherapeuticsSanjeev Thohan
Scientific Advisory Board Member Cogentis Therapeutics/ Phoenix Molecular DesignsYuhua Ji
Vice President, Drug Discovery Grace Science, LLCYoshi Satoh
Vice President of Chemistry Rev TherapeuticsSee Which Topics Are Up For Discussion
A Deep Dive into the Synergies of Artificial Intelligence and Drug Discovery for Precision Medicine
Roundtable Tracks
1The Evolution Of AI: Looking Back At The Past 10 Years And Projecting The Future 10
-Andrea Small-Howard
President
GB Sciences
Chemical Biology, Targeted Protein Degradation & Undruggables / Innovative & Emerging Modalities
Identifying “Difficult-to-Drug” Targets with Chemical Biology Approaches
Hit Identification / Lead Optimization
Using Computational Methods To Improve Precision And Efficiency In Lead Optimization And Hit Identification
-Lalit K Sharma
Co-founder and CSO
NoraChem
Design & Synthesis
Designing the Next Generation of Drugs: Harnessing Physicochemical Properties, Streamlining Processes, and Innovating Chemical Technologies
-Arun Thottumkara
Director of Chemistry, Enabling Science
Odyssey Therapeutics
Integrated Drug Discovery
Leveraging ADME-PKPD relationships and mechanistic toxicology while building bridges between translational sciences is crucial for effective drug development, spanning from molecules to medicines
-Sanjeev Thohan
Scientific Advisory Board Member
Cogentis Therapeutics/ Phoenix Molecular Designs
Roundtable Tracks
2AI in Drug Discovery: Advancements in Ligand-Based Predictive Modeling for Novel Drug Design
-Frederick Chang
CEO
Kekulai
SPONSOR
Chemical Biology, Targeted Protein Degradation & Undruggables / Innovative & Emerging ModalitiesAccelerating innovation in drug modalities research through CRO, CDMO, CMO, and academia partnerships
-Chris Stumpf
Senior Principal Product Marketing Manager for Drug Discovery Informatics Solutions
Revvity Signals
REVVITY SIGNALS
Hit Identification / Lead OptimizationEfforts for “Failing Fast and Failing Early.” i.e., What to Do Early in Lead Generation and Lead Optimization
-Yuhua Ji
Vice President, Drug Discovery
Grace Science, LLC
Design & Synthesis
Small Business, Big Impact: How Partnering with Small Businesses Provides Sustainable Growth & Individualized Solutions
-Dustin Cefalo, Ph.D
Vice President of Chemistry
FRONTIER
Frontier Specialty Chemicals
Integrated Drug DiscoveryAccelerating innovation in drug modalities research through CRO, CDMO, CMO, and academia partnerships
SPONSOR
Roundtable Tracks
3Leveraging Generative Modeling to Accelerate Drug Discovery
-Philip Cheung
Founder and Chief Executive Officer
Refactor Biosciences
Chemical Biology, Targeted Protein Degradation & Undruggables / Innovative & Emerging Modalities
Exploring the Current Formulation Challenges in Undruggable Leads
-Bryce Allen
Co-founder & CEO
Differentiated Therapeutics
Hit Identification / Lead Optimization
Utilizing Molecular Dynamics (MD) Simulations for Fragment-Based Drug Design: What are the Advantages and Disadvantages?
Design & Synthesis
Design And Synthesis In The Age Of AI And Biologic-Small Molecule Hybrids
-Thomas Brady
Senior Principal Scientist
Cidara Therapeutics
Integrated Drug Discovery
Ideas About Automating Decision Making Steps To Accelerate Integrated Discovery
-Yoshi Satoh
Vice President of Chemistry
Rev Therapeutics
Roundtable Tracks
4Revolutionizing Drug Discovery: Unleashing AI and Generative Modeling for Molecular Innovation.
-Prasun Mishra
CEO, Founder / CEO, Founding President
r, Agility Pharmaceuticals / American Association for Precision Medicine (AAPM)
Chemical Biology, Targeted Protein Degradation & Undruggables / Innovative & Emerging Modalities
Methods Of Computation And Cheminformatics For Chemical Synthesis And Hit Finding For Tough Targets And New Therapeutic Approaches
Hit Identification / Lead Optimization
Exploring challenges and triumphs using Integrated Drug Discovery in lead optimization, candidate selection and IND enabling studies.
-Brock Shireman
Vice President, Head of Chemistry
Rapport Therapeutics
Design & Synthesis
Pioneering Perspectives and Forward- thinking Approaches in Design and Synthesis for Drug Discovery
-Yoshi Satoh
Vice President of Chemistry
Rev Therapeutics
Integrated Drug Discovery
Lessons Learned and Ongoing Effort: Drug Discovery Beyond the Rule of Five
-Yuhua Ji
Vice President, Drug Discovery
Grace Science, LLC
Bridging Science And Investment: A Dialogue On Drug Discovery Venture Strategies Biotech Progress And The Revolutionary Landscape Of Pharmaceuticals
Reasons To Attend Our Strategy Meetings
Fully Interactive Format
There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter
Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard
Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you
Private and Intimate Networking
Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution
Press play to hear what your colleagues had to say…
Hotel & Venue
Hard Rock Hotel San Diego
You’re the main act in San Diego. At Hard Rock Hotel, we immerse you in our musical amenities, world-class service, and intoxicating location in downtown San Diego. Tour the Gaslamp Quarter on an Electra bike and walk a block to Petco Park.
Hotel Details Map & Directions ParkingHere To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.